170901-07-2

Basic information

• Product Name: 13BETA-ETHYL-11ALPHA-HYDROXYANDROST-4-ENE-3,17-DIONE
• Synonyms: 13BETA-ETHYL-11ALPHA-HYDROXYANDROST-4-ENE-3,17-DIONE
• CAS NO: 170901-07-2
• Molecular Formula: C21H30O3
• Molecular Weight: 302.41
• Mol File: 170901-07-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 489.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.19±0.1 g/cm3(Predicted)
• PKA: 14.48±0.40(Predicted)
• CAS DataBase Reference: 13BETA-ETHYL-11ALPHA-HYDROXYANDROST-4-ENE-3,17-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 13BETA-ETHYL-11ALPHA-HYDROXYANDROST-4-ENE-3,17-DIONE(170901-07-2)
• EPA Substance Registry System: 13BETA-ETHYL-11ALPHA-HYDROXYANDROST-4-ENE-3,17-DIONE(170901-07-2)

Safety Data

• Hazardous Substances Data: 170901-07-2(Hazardous Substances Data)

Upstream product

• 21800-83-9 13β-ethyl-gon-4-en-3,17-dione 
• 19882-75-8 13-Ethyl-3-methoxygona-1,3,5⁽¹⁰⁾,9⁽¹¹⁾-tetraen-17-one 
• 24957-65-1 DL-13β-ethyl-11β-hydroxy-gona-4,9-dien-3,17-dione 
• 20799-05-7 DL-13β-ethyl-gona-4,9-diene-3,17-dione 
• 2322-77-2 13β-ethyl-3-methoxygona-2,5(10)-diene-17-one 
• 4222-96-2 DL-13β-ethyl-gon-5(10)-ene-3,17-dione 
• 140221-18-7 (8S,13S,14S)-13-Ethyl-1,4,6,7,8,12,13,14,15,16-decahydro-2H-cyclopenta[a]phenanthrene-3,17-dione 
• 141300-07-4 (8S,11S,13S,14S)-13-Ethyl-11-hydroperoxy-1,6,7,8,11,12,13,14,15,16-decahydro-2H-cyclopenta[a]phenanthrene-3,17-dione 

Downstream Products

• 1574323-07-1 C₂₁H₃₀O₄ 
• 1574323-08-2 C₂₂H₃₂O₃ 
• 54024-22-5 desogestrel 
• 54048-10-1 etonogestrel 

Relevant articles and documents

A novel and efficient process to 13β-ethyl-gon-4-ene-3,11,17-trione

A novel synthetic process to 13β-ethyl-gon-4-ene-3,11,17-trione with the total yield of 44% starting from 13β-ethyl-17β-hydroxy-3-methoxy-gona-2,5(10)-diene was described.

PROCESS FOR THE SELECTIVE ISOLATION, PURIFICATION AND SEPARATION OF MONOHYDROXYLATED 3,17-DIKETO-STEROID COMPOUNDS

The subject of the present invention is a new process for the selective isolation, purification and separation of monohydroxylated 3,17-diketo-steroid compounds from a solution obtained preferably by microbiological way containing a mixture of steroid compounds via selective extraction, purification and selective crystallization of the steroid compounds by treatment of several solvents.